Federal safety officials say about 1.72 million Cuisinart grill brushes may shed metal bristles, posing an ingestion risk; Conair will offer refunds.

A $16M campaign at Cooley Dickinson has closed, funding a roughly 40% expansion of the Emergency Department along with new behavioral‑health rooms and a 'You Are Welcome Here' plaque.

A $2.75M settlement resolves allegations that Bear Mountain knowingly understaffed homes. Timberlyn Heights gets $1M and three years of independent monitoring.

A mosquito sample from Clarksburg tested positive for West Nile virus, the first of the season in Massachusetts. Officials say no human cases have been reported and urge precautions.

Babesiosis and other tick‑borne infections are rising in Massachusetts, and rare Powassan infections are drawing increased concern from clinicians and families. Experts blame climate, deer and sprawl.

Boston recorded 120 opioid overdose deaths in 2025 — the fewest in a decade — as naloxone distribution and outreach expanded citywide.

Cambridge Health Alliance will reopen its Birth Center on July 6 with midwifery‑led deliveries, water‑birth tubs and a 19‑doula multilingual team.

A 66-year-old Concord man is critically ill at Massachusetts General after contracting the rare Powassan tick-borne virus. Health officials are reminding people to take simple tick precautions.

Boston Herald reporting expands the count to 11 Newton‑Wellesley nurses diagnosed with brain tumors and publishes a case breakdown while hospital and union disagree on cause.

State data show behavioral-health prescriptions climbed from 2019–2024, with women ages 18–49 seeing the biggest increases.

A biomarker analysis of more than 30,000 adults found that most people who meet the 'five-a-day' guideline still fall short of the 500 mg/day flavanol level linked to lower heart deaths.

Three Connecticut children died after apparent diphenhydramine overdoses as doctors warn the 'Benadryl Challenge' may be returning. Pediatricians urge parents to secure OTC meds and call Poison Control.

A Harvard analysis finds no clear rise in birth defects after early exposure to GLP-1 weight-loss drugs, though doctors still recommend stopping before conception.